MedRhythms Inc., a Portland health technology startup, is beginning a new clinical trial of the company’s digital therapeutic device for walking impairments related to Parkinson’s disease.
The multisite study will be conducted through a collaboration with Boston University and a leading hospital, and will evaluate the efficacy of the device when used at home, according to a news release.
MedRhythms, launched in 2016, is developing systems with clinical-grade sensors, music and artificial intelligence to measure and improve walking for people with neurological injuries or diseases. Read more
